JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
76 hedge funds and large institutions have $239M invested in Jounce Therapeutics, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 38 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
76
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$16M | |
| 2 | +$5.7M | |
| 3 | +$5.05M | |
| 4 |
CC
Casdin Capital
New York
|
+$3.74M |
| 5 |
FI
Fosun International
Hong Kong,
China
|
+$3.01M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$8.72M | |
| 3 | -$3.48M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$2.85M |
| 5 |
Millennium Management
New York
|
-$2.26M |